Welcome to Anagrammer Crossword Genius! Keep reading below to see if acterio is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on acterio.
acterio
Searching in Crosswords ...
The answer ACTERIO has 0 possible clue(s) in existing crosswords.
Searching in Word Games ...
The word ACTERIO is NOT valid in any word game. (Sorry, you cannot play ACTERIO in Scrabble, Words With Friends etc)
There are 7 letters in ACTERIO ( A1C3E1I1O1R1T1 )
To search all scrabble anagrams of ACTERIO, to go: ACTERIO?
Rearrange the letters in ACTERIO and see some winning combinations
Scrabble results that can be created with an extra letter added to ACTERIO
7 letters out of ACTERIO
5 letters out of ACTERIO
4 letters out of ACTERIO
3 letters out of ACTERIO
Searching in Dictionaries ...
Definitions of acterio in various dictionaries:
No definitions found
Word Research / Anagrams and more ...
Keep reading for additional results and analysis below.
Acterio might refer to |
---|
Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel in Switzerland.Actelion specializes in orphan diseases. Actelion scientists were among the first to work in the field of endothelian receptor antagonists. The company name might be a reminder for its first product, an endothelian receptor antagonist and the verb "action", "act upon". Actelion was initially financed with venture capital provided through a syndicate including Atlas Venture, Sofinnova and HealthCap. * Actelion has 29 operative affiliates around the world, including the United States, Canada, Brazil, Australia, Japan, Switzerland and a number of EU countries. * The Swiss affiliate is located in Baden, the German affiliate in Freiburg, the Austrian one in Vienna, the French one in Paris and the UK affiliate is located in LondonIn 2006, the company established the Actelion Endothelin Research Award programme which supports selected clinical research projects. * In January 2017, Johnson & Johnson announced that it would purchase the company for $30 billion. Actelion's research and development unit would also be spun off after the acquisition. The new company Idorsia was created from former Actelion drug discovery operations and early-stage clinical development assets and listed in June 2017 on the SIX Swiss Exchange.In 2018, Johnson & Johnson announced they would discontinue development of one of the phase III drugs it acquired during its purchase of Actelion. |